Tenax Therapeutics, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 31/07/2026 | Mar 2026Filed 31/07/2026 | Sep 2025Filed 12/11/2025 | Jun 2025Filed 31/07/2026 | Mar 2025Filed 31/07/2026 | Sep 2024Filed 12/11/2025 | Jun 2024Filed 12/11/2025 | Mar 2024Filed 12/11/2025 |
|---|---|---|---|---|---|---|---|---|
| — | $0 | — | — | $0 | — | — | — | |
| −$18 | −$16 | −$16 | −$11 | −$10 | −$4 | −$3.6 | −$3.8 | |
| −$0.35 | −$0.35 | −$0.40 | −$0.27 | −$0.28 | −$0.19 | −$1.83 | −$3.12 | |
| 51 | 45 | 40 | 40 | 37 | 21 | 2 | 1.2 |
Trend